Axe Compute Inc(AGPU) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -145.45 | Insider Own | 31.4% | Shs Outstand | 11.4M | Perf Week | 0.48% |
| Market Cap | 0.15B | Forward P/E | - | EPS next Y | 93.68% | Insider Trans | 0.24% | Shs Float | 8.0M | Perf Month | 26.51% |
| Enterprise Value | 0.13B | PEG | - | EPS next Q | -0.29 | Inst Own | 4.25% | Short Float | 7.45% | Perf Quarter | 65.57% |
| Income | -0.25B | P/S | 44.62 | EPS this Y | -169.89% | Inst Trans | 1.89% | Short Ratio | 1.35 | Perf Half Y | 753.74% |
| Sales | 0.00B | P/B | 4.2 | EPS next 5Y | - | ROA | -488.39% | Short Interest | 0.59M | Perf YTD | 75.52% |
| Book/sh | 2.99 | P/C | 6.64 | EPS past 3/5Y | 49.83% 54.21% | ROE | -1565.24% | 52W High | -60.9% ($32.10) | Perf Year | -30.28% |
| Cash/sh | 1.89 | P/FCF | - | Sales past 3/5Y | -56.34% -36.9% | ROIC | -733.09% | 52W Low | 1118.45% ($1.03) | Perf 3Y | -73.85% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -591.53% | Gross Margin | -14.84% | Volatility(W/M) | 8.73% 9.09% | Perf 5Y | -96.76% |
| Dividend TTM | - | EV/Sales | 38.41 | Sales Y/Y TTM | 204.84% | Oper. Margin | -953.64% | ATR (14) | 1.04 | Perf 10Y | -99.9% |
| Dividend Ex-Date | - | Quick Ratio | 1.45 | EPS Q/Q | 74.37% | Profit Margin | -7770.02% | RSI (14) | 62.04 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.45 | Sales Q/Q | 119772.93% | SMA20 | 10.93% ($11.31) | Beta | 3.68 | Target Price | $20 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 2026/8/14 | SMA50 | 26.99% ($9.88) | Rel Volume | 1.02 | Prev Close | $12.15 |
| Employees | 14 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | - | SMA200 | 100.97% ($6.24) | Avg Volume(3M) | 0.44M | Price | $12.55 |
| IPO | 2010/4/9 | Option/Short | No/Yes | Trades | 3928 | Volume | 446,086 | Change | 3.29% |
🖥️ This U.S.-listed company has pivoted its business focus to distributed artificial intelligence computing infrastructure services. Originally known as Predictive Oncology, an oncology drug discovery company, it has changed its name and now operates a structure that provides enterprise customers with access to bare-metal graphics computing resources through the Aethir network.
Over the past 1 year, roughly in the middle
61% below its 1-year high.
Traded about as much as usual That is 102% of its average volume.
AGPU has a sound balance sheet but weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -169.9% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $4,462. Peers typically go for $145.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -96.8%. The S&P 500 did +76% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 4.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #125 of 180 in the industry
Based on market cap of $145M.
FAQ
What kind of company is AGPU?
AGPU belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of AGPU?
The market cap of AGPU is approximately $145M, ranking 4,319 within its sector.
What is the 52-week high and low for AGPU?
AGPU has recorded a 52-week high of $32.10 and a low of $1.03.